Theaflavin-3,3′-Di-Gallate Represses Prostate Cancer by Activating the PKCδ/aSMase Signaling Pathway through a 67 kDa Laminin Receptor

The anti-prostate cancer effect of TF-3 was attributed to the expression of the 67 kDa laminin receptor (67LR), which is overexpressed in various cancers, playing a vital role in the growth and metastasis of tumor cells.